MIRA INFORM REPORT

 

 

Report Date :

03.01.2011

 

IDENTIFICATION DETAILS

 

Correct Name :

NAWABSONS LABORATORIES (PVT) LIMITED

 

 

Registered Office :

7-A, Friends Colony, Multan Road, Lahore

 

 

Country :

Pakistan

 

 

Year of Establishment :

1972

 

 

Com. Reg. No.:

0003839

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Manufacture & Marketing of Pharmaceutical Products

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

                   (01.04.2010)                  

Current Rating

(30.06.2010)

Pakistan

b1

b1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Business Name

 

NAWABSONS LABORATORIES (PVT) LIMITED

 

 

Full Address       

 

Registered Address

7-A, Friends Colony, Multan Road, Lahore, Pakistan

                       

Tel #

92 (42) 37561743, 37574961

Fax #

92 (42) 37574961

Email

nobsons@nexlinx.net.pk

 

 

Short Description Of Business

 

a.

Nature of Business           

Manufacture & Marketing of Pharmaceutical Products

b.

Year Established

1972

c.

Registration #

0003839

 

 

Factory Location 

           

Jia Bagga Off Raiwind Road,

Lahore, Pakistan

 

 

Auditors

 

Naeem Tariq & Co.

(Chartered Accountants)

2nd Floor, Suite No. 7-8, Rahim Complex, Main Market, Gulberg II, Lahore, Pakistan

 

 

Legal Status

 

Subject Company was established as a Private Limited Company in 1972

 

 

 

Authorized Capital

Rs. 42,000,000/- divided into 420,000 shares of Rs. 100/- each

Issued & Paid up Capital

Rs. 22,000,000/- divided into 220,000 shares of Rs. 100/- each

 

 

Details of Directors

 

Names

Designation

Mr. Akhtar Hussain Bhutta

 

Mr. Arjumand Akhtar

 

Mr. Nadeem Akhtar

Chief Executive

 

Director

 

Director

 

 

Shareholders                

 

Names

No. of Shares

Mr. Akhtar Hussain Bhutta

 

Mr. Arjumand Akhtar

 

Mr. Nadeem Akhtar

 

Mr. Fauqia Akhtar

 

Mrs. Uzma Akhtar

 

Mrs. Naushaba Arjumand

 

Mrs. Sehar Nadeem

5,060

 

106,285

 

106,285

 

285

 

285

 

900

 

900

 

 

Associates                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

 

A.         Subsidiary

 

 

            None                                            

 

B.         Associated Companies

 

(1) Asad Traders, Pakistan.

 

 

 

Products

 

Manufacture & Marketing of Pharmaceutical Products by its brand names of ASCORBION, ASPIRIN COMP, ASPIRIN SOLUBLE, B-COMPLEX LYSINE, CIMETIDINE, COTRIMOXAZOLE, DIAZEPAM, DIPHENHY DRAMINE, HEMAFER, MULTIVITAMIN, PIPERAZINE CITRATE, POVIDONE IODINE SOLN 

           

 

Number of Employees

 

82        

 

 

Annual Production Volume

 

The capacity and production of the company’s plant is indeterminable as it is multi-product and involves varying processes of manufacturing.

 

 

Annual Sales Volume

 

Year

In Pak Rupees

2009

100,000,000/- (Estimated)

 

Trade Suppliers

(Foreign)

 

Subject mainly import from Companies belongs to China & India

 

 

Distributors

 

Mainly exist at all major cities of Pakistan

 

Bankers

 

·         The Bank of Punjab, Pakistan.

·         Bank Alfalah Limited, Pakistan.

·         Habib Bank Limited, Pakistan.

·         United Bank Limited, Pakistan.

 

 

Memberships

 

·         Pakistan Pharmaceutical Manufacturers Associations.(PPMA)

·         Lahore Chamber of Commerce & Industry.(LCCI)

 

Foreign Exchange Rates

 

Currency

 

Unit

Pakistani Rupee

US Dollar

1

           Rs. 85.60

UK Pound

1

           Rs. 132.15

Euro

1

           Rs. 112.00

 

 

Comments

 

Subject Company was established in 1972 and is engaged in manufacture & marketing of Pharmaceutical Products. Overall reputation is normal. Trade relations are reported as fair. Subject can be considered for normal business dealings at usual trade terms & conditions.

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.44.81

UK Pound

1

Rs.59.81

Euro

1

Rs.69.29

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.